<code id='427EA89D69'></code><style id='427EA89D69'></style>
    • <acronym id='427EA89D69'></acronym>
      <center id='427EA89D69'><center id='427EA89D69'><tfoot id='427EA89D69'></tfoot></center><abbr id='427EA89D69'><dir id='427EA89D69'><tfoot id='427EA89D69'></tfoot><noframes id='427EA89D69'>

    • <optgroup id='427EA89D69'><strike id='427EA89D69'><sup id='427EA89D69'></sup></strike><code id='427EA89D69'></code></optgroup>
        1. <b id='427EA89D69'><label id='427EA89D69'><select id='427EA89D69'><dt id='427EA89D69'><span id='427EA89D69'></span></dt></select></label></b><u id='427EA89D69'></u>
          <i id='427EA89D69'><strike id='427EA89D69'><tt id='427EA89D69'><pre id='427EA89D69'></pre></tt></strike></i>

          hotspot

          hotspot

          author:Wikipedia    Page View:2378
          HHS 2020
          PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

          WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

          The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

          advertisement

          PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Weighted lottery helped low
          Weighted lottery helped low

          AmedicalassistantataUniversityofWashingtonMedicineclinicpreparesatwo-shotdoseofEvusheldinJanuary2022

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Readout Newsletter: Biotech news, including Moderna's Covid vaccine

          RONNYHARTMANN/AFPviaGettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup tog